| Christopher J Salgado, MD | |
|
1675 Micanopy Ave, Miami, FL 33133-2542 | |
| (267) 694-1282 | |
| Not Available |
| Full Name | Christopher J Salgado |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 29 Years |
| Location | 1675 Micanopy Ave, Miami, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124100599 | NPI | - | NPPES |
| 000000559896 | Other | OH | ANTHEM |
| 2829041 | Medicaid | OH | |
| P00471412 | Other | OH | RAILROAD MEDICARE |
| 7691746 | Other | OH | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 35.091065 (Ohio) | Secondary |
| 208200000X | Plastic Surgery | MA07880100 (New Jersey) | Secondary |
| 208600000X | Surgery | ME93100 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Palmetto General Hospital | Hialeah, FL | Hospital |
| Larkin Community Hospital Palm Springs Campus | Hialeah, FL | Hospital |
| Entity Name | Sultan Sol Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497212500 PECOS PAC ID: 6406181510 Enrollment ID: O20190711002310 |
News Archive
Two faculty members at Tufts University have been elected Fellows of the American Association for the Advancement of Science (AAAS), an honor bestowed upon AAAS members by their peers. John M. Coffin and planetary scientist Samuel P. Kounaves are among 388 new Fellows recognized by AAAS based on their distinguished efforts to advance science or its applications.
Bone marrow transplants of hematopoietic stem cells have become standard treatment for a host of conditions including cancers of the blood and lymphatic systems, sickle cell anemia, inherited metabolic disorders, and radiation damage.
Researchers at the Children's Hospital Colorado Breathing Institute, the largest pediatric cystic fibrosis (CF) clinical care center in the U.S., participated in the pivotal international multi-center Phase 3 clinical trial, sponsored by Vertex Pharmaceuticals Incorporated, leading to FDA approval of TRIKAFTA (elexacaftor/tezacaftor/ivacaftor), a highly effective CF treatment, for patients ages 6 through 11 who have at least one copy of the F508del mutation.
Chemotherapy often shrinks tumors at first, but as cancer cells become resistant to drug treatment, tumors can grow back. A new nanodevice developed by MIT researchers can help overcome that by first blocking the gene that confers drug resistance, then launching a new chemotherapy attack against the disarmed tumors.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher J Salgado, MD 1675 Micanopy Ave, Miami, FL 33133-2542 Ph: (305) 243-7500 | Christopher J Salgado, MD 1675 Micanopy Ave, Miami, FL 33133-2542 Ph: (267) 694-1282 |
News Archive
Two faculty members at Tufts University have been elected Fellows of the American Association for the Advancement of Science (AAAS), an honor bestowed upon AAAS members by their peers. John M. Coffin and planetary scientist Samuel P. Kounaves are among 388 new Fellows recognized by AAAS based on their distinguished efforts to advance science or its applications.
Bone marrow transplants of hematopoietic stem cells have become standard treatment for a host of conditions including cancers of the blood and lymphatic systems, sickle cell anemia, inherited metabolic disorders, and radiation damage.
Researchers at the Children's Hospital Colorado Breathing Institute, the largest pediatric cystic fibrosis (CF) clinical care center in the U.S., participated in the pivotal international multi-center Phase 3 clinical trial, sponsored by Vertex Pharmaceuticals Incorporated, leading to FDA approval of TRIKAFTA (elexacaftor/tezacaftor/ivacaftor), a highly effective CF treatment, for patients ages 6 through 11 who have at least one copy of the F508del mutation.
Chemotherapy often shrinks tumors at first, but as cancer cells become resistant to drug treatment, tumors can grow back. A new nanodevice developed by MIT researchers can help overcome that by first blocking the gene that confers drug resistance, then launching a new chemotherapy attack against the disarmed tumors.
› Verified 2 days ago
Dr. Gladys Linda Giron, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 8900 N Kendall Dr, Miami, FL 33176 Phone: 786-596-2000 | |
Dr. Alan S Serure, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 7300 S.w. 62 Place, Suite 200, Miami, FL 33143 Phone: 305-669-0184 Fax: 305-669-0720 | |
Dr. Ascension M Torres, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 11760 Sw 40th St, Suite 722, Miami, FL 33175 Phone: 305-559-1883 Fax: 305-559-1887 | |
Dr. Geoffrey David Young, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 8900 N. Kendall Dr, Miami Cancer Institute, Miami, FL 33176 Phone: 786-596-2000 Fax: 305-279-7778 | |
Dr. Tihesha L Wilson, MD Surgery Medicare: Medicare Enrolled Practice Location: 3641 S Miami Ave, Suite 331, Miami, FL 33133 Phone: 305-285-5040 Fax: 305-285-5039 | |
Henri Ronald Ford, MD Surgery Medicare: Medicare Enrolled Practice Location: 1611 Nw 12th Ave, Miami, FL 33136 Phone: 305-585-5437 | |
Humphrey C. Jones, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1190 Nw 95th St, Suite 301, Miami, FL 33150 Phone: 305-694-1374 Fax: 305-694-1376 |